T lymphocyte activation following OKT3 treatment.
Ellenhorn
J D
JD
Department of Surgery, University of Chicago, Illinois.
Woodle
E S
ES
Thistlethwaite
J R
JR
Bluestone
J A
JA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007376:Interleukin-2